David Peritt

Founder and CSO

‍Lupagen

Founder and CSO

‍Lupagen

#celltherapies #medicine #science

#NorthAmerica

A proven track record in bringing innovative therapies from inception to the clinic and beyond. Early team building, setting strategic direction and execution. 25+ years of industry experience leading

James Piret

Professor, Michael Smith Laboratories

‍The University of British Columbia

Professor, Michael Smith Laboratories

‍The University of British Columbia

#celltherapies #immunecell #biotechnology

#NorthAmerica

James Piret is Professor, Michael Smith Laboratories at The University of British Columbia

Lee Buckler

Managing Director

‍Cell Therapy Group

Managing Director

‍Cell Therapy Group

#celltherapy #celltherapies #cellgenetherapy #regenerativemedicine #celltherapymanufacturing

#NorthAmerica

Passionate about helping the cell therapy industry grow, mature, and thrive. My experience spans business development and senior management of CDMOs, non-profits, service and tools companies, and ther

Markus P. Vallaster

Executive Medical Director - Cell Therapies and Immuno-OncologyExecutive Medical Director - Cell Therapies and Immuno-Oncology

‍AstraZeneca

Executive Medical Director - Cell Therapies and Immuno-OncologyExecutive Medical Director - Cell Therapies and Immuno-Oncology

‍AstraZeneca

#CellTherapies #Immuno-Oncology

#NorthAmerica

Adaptive clinical trial designs, Bayes acolyte, immune-imaging using novel PET-based technologies.